CTLA4 and neoplasm: Indeed, tumor cells can upregulate cytotoxic T lymphocyte antigen (CTLA)-4 or programmed death ligand 1 (PD-L1), which can inhibit T cells by competing with the stimulatory signal of CD28 and by triggering inhibitory receptor programmed cell death 1 (PD1), respectively [20].